November 12, 2023 Comments Off on AI-Driven Strategies: Pharma’s Answer to Patent Expirations Posted in: Insights In a recent article in Pharmaceutical Executive, Alan Kalton, Senior Vice President of Commercial Strategy at Aktana, sheds light on the critical challenges facing pharmaceutical companies as they confront impending…
The post AI-Driven Strategies: Phar…
November 6, 2023 Comments Off on Maximizing Intellectual Property Value in the Biomedical Sector: A Case Study on Rucaparib Patents Posted in: Insights A paper titled “Analysis of Strategy for Extending Patent Protection of Rucaparib” by Zhifeng Wang. discusses the strategies employed by pharmaceutical companies to extend the patent protection period of the…
The post Maximizing Intellectual Property V…